UK markets close in 1 hour 29 minutes

HCA Healthcare, Inc. (HCA)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
237.40-6.20 (-2.55%)
As of 10:01AM EST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 78.99B
Enterprise value 112.01B
Trailing P/E 12.98
Forward P/E 13.59
PEG ratio (5-yr expected) 0.94
Price/sales (ttm)1.47
Price/book (mrq)N/A
Enterprise value/revenue 1.93
Enterprise value/EBITDA 8.20

Trading information

Stock price history

Beta (5Y monthly) 1.66
52-week change 348.42%
S&P500 52-week change 314.56%
52-week high 3269.75
52-week low 3156.43
50-day moving average 3245.65
200-day moving average 3233.89

Share statistics

Avg vol (3-month) 31.39M
Avg vol (10-day) 31.45M
Shares outstanding 5311.02M
Implied shares outstanding 6N/A
Float 8238.49M
% held by insiders 122.94%
% held by institutions 169.41%
Shares short (30 Dec 2021) 43.5M
Short ratio (30 Dec 2021) 42.35
Short % of float (30 Dec 2021) 41.46%
Short % of shares outstanding (30 Dec 2021) 41.13%
Shares short (prior month 29 Nov 2021) 42.82M

Dividends & splits

Forward annual dividend rate 41.92
Forward annual dividend yield 40.80%
Trailing annual dividend rate 31.44
Trailing annual dividend yield 30.59%
5-year average dividend yield 4N/A
Payout ratio 47.36%
Dividend date 328 Dec 2021
Ex-dividend date 412 Dec 2021
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sept 2021


Profit margin 11.33%
Operating margin (ttm)16.70%

Management effectiveness

Return on assets (ttm)12.03%
Return on equity (ttm)474.39%

Income statement

Revenue (ttm)57.98B
Revenue per share (ttm)175.29
Quarterly revenue growth (yoy)14.80%
Gross profit (ttm)19.23B
Net income avi to common (ttm)6.57B
Diluted EPS (ttm)19.53
Quarterly earnings growth (yoy)239.70%

Balance sheet

Total cash (mrq)1.14B
Total cash per share (mrq)3.66
Total debt (mrq)34.06B
Total debt/equity (mrq)1,866.30
Current ratio (mrq)1.38
Book value per share (mrq)-2.22

Cash flow statement

Operating cash flow (ttm)2.93B
Levered free cash flow (ttm)-2.14B